"ovarian borderline tumor histologic" trang 3 - tải miễn phí từ tailieunhanh
Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer

Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer
13    54    1
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients

Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
7    53    1
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
8    32    1
METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells

METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells
15    65    1
The milk-derived fusion peptide, ACFP, suppresses the growth of primary human ovarian cancer cells by regulating apoptotic gene expression and signaling pathways

The milk-derived fusion peptide, ACFP, suppresses the growth of primary human ovarian cancer cells by regulating apoptotic gene expression and signaling pathways
14    76    1
Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy

Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy
11    42    1
Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens

Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens
15    52    1
Comparison of the prognosis and recurrence of apparent early-stage ovarian tumors treated with laparoscopy and laparotomy: A meta-analysis of clinical studies

Comparison of the prognosis and recurrence of apparent early-stage ovarian tumors treated with laparoscopy and laparotomy: A meta-analysis of clinical studies
7    36    1
Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma

Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma
10    28    1
Acrokeratosis paraneoplastica in serous ovarian carcinoma: Case report

Acrokeratosis paraneoplastica in serous ovarian carcinoma: Case report
4    32    1
A late, solitary brain metastasis of epithelial ovarian carcinoma

A late, solitary brain metastasis of epithelial ovarian carcinoma
4    35    1
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker
13    41    1
MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
10    41    1
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
10    84    1
Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer

Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer
9    51    1
Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
12    65    1
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
9    36    1
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients
9    55    1
Production of monoclonal antibody to quantify serum CA125 concentration in breast and ovarian cancer patients

Production of monoclonal antibody to quantify serum CA125 concentration in breast and ovarian cancer patients
8    79    2
Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer

Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
13    49    1